http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2396086-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c125b04ebd96d94d3a72dbde01d295b6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate | 2005-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db84ff296fbd1ed2bfe88c519ec3d7cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b586999e11822828e9fd5c739ff7155 |
| publicationDate | 2010-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2396086-C2 |
| titleOfInvention | Methods of treating tracheal, bronchial or alveolar haemorrhage or hemoptysis |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine and concerns methods of treating tracheal, bronchial or alveolar haemorrhage or haemoptysis. Substance of the invention involves intratracheal, intrabronchial or intraalveolar introduction to a person of a blood-coagulation factor which is activated factor VII. n EFFECT: advantage of the invention consists in application of the blood-coagulation factor active at the earlier stages of the coagulation cascade. n 16 cl, 1 ex |
| priorityDate | 2004-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.